Deleterious effects of IL-9 -activated mast cells and neuroprotection by antihistamine drugs in the developing mouse brain

Pediatric Research

Volumn 50, Issue 2, 2001, Pages 222-230

  Patkai, Juliana ^a   Mesples, Bettina ^a   Dommergues, Marie Aliette ^a   Fromont, GaËlle ^b   Thornton, Elisabeth M ^c   Renauld, Jean Christophe ^d   Evrard, Philippe ^a   Gressens, Pierre ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b INSTITUT MUTUALISTE MONTSOURIS   (France)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CROMOGLYCATE DISODIUM; DEXCHLORPHENIRAMINE MALEATE; IBOTENIC ACID; RANITIDINE; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT INTERLEUKIN 9; THIOPERAMIDE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BRAIN DEVELOPMENT; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; MAST CELL; MORTALITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

EID: 0034915682     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200108000-00010     Document Type: Article

References (31)

1. Birthweight specific trends in cerebral palsy
2. Antecedents of cerebral palsy: Multivariate analysis of risk
3. Normal and abnormal development of the brain
4. Environmental determinants of brain development, with a special emphasis on the excitotoxic cascade at the consecutive developmental steps
5. Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies
6. Periventricular leukomalacia: Risk factors revisited
7. Neonatal cytokines and coagulation factors in children with cerebral palsy
8. Effect of ibotenate on brain development: An excitotoxic mouse model of microgyria and posthypoxic-like lesions
9. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain
10. Pro-inflammatory cytokines and IL-9 exacerbate excitotoxic lesions of the newborn murine neopallium
11. Interleukin 9 and its receptor: An overview of structure and function
12. Mast cells in mammalian brain
13. Mast cells in the human brain
14. Migration of mast cells in the developing brain
15. Distribution and local differentiation of mast cells in the parenchyma of the forebrain
16. Mast cells in the neonate musk shrew brain: Implications for neuroendocrine immune reactions
17. Mast cell in the brain: Evidence and functional significance
18. Mast cell interactions with the nervous system: Relationship to mechanisms of disease
19. Distribution and local differentiation of mast cells in the parenchyma of the forebrain
20. Systemic administration of anti-NOS and anti-glycine protects against excitotoxic lesions in the developing mouse brain
21. Patterns of excitability changes and glucose metabolism in experimentally induced cortical dysplasias
22. Magnesium-deficiency-dependent audiogenic seizures (MDDASs) in adult mice: A nutritional model for discriminatory screening of anticonvulsant drugs and original assessment of neuroprotection properties
23. Mast cell heterogeneity in the gastrointestinal tract: Variable expression of mouse mast cell protease-1 (mMCP-1) in intraepithelial mucosal mast cells in nematode-infected and normal BALB/c mice
24. The analysis of mast cell function in vivo using mast-cell deficient mice
25. Cytokine regulation of neuronal differentiation of hippocampal progenitor cells
26. 2+) signalling systems
27. Functional diversity of histamine and histamine receptors
28. 2 receptor activates adenylate cyclase and PLC via separate GTP-dependent pathways
29. Characterisation of a functional polyamine site on rat mast cells: Association with a NMDA receptor macrocomplex
30. Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice